Imatinib Mesylate 60505-2901-03
- Manufacturer
- Apotex Corp
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 5, 2016
- Listing Expires
- December 31, 2027
- Application
- ANDA079179
Need to source Imatinib Mesylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Imatinib Mesylate | 400 mg/1 |
Drug Class
Bcr-Abl Tyrosine Kinase Inhibitors [MoA]Cytochrome P450 2D6 Inhibitors [MoA]Cytochrome P450 3A4 Inhibitors [MoA]
Selected Package
60505-2901-03Selected30 TABLET, FILM COATED in 1 BOTTLE (60505-2901-3)
Other packages for this product(4)
10 BLISTER PACK in 1 CARTON (60505-2901-0) / 10 TABLET, FILM COATED in 1 BLISTER PACK
100 TABLET, FILM COATED in 1 BOTTLE (60505-2901-1)
500 TABLET, FILM COATED in 1 BOTTLE (60505-2901-5)
90 TABLET, FILM COATED in 1 BOTTLE (60505-2901-9)